Aspiriant LLC’s Nike NKE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,550
| Closed | -$225K | – | 314 |
|
|
2025
Q1 | $225K | Sell |
3,550
-496
| -12% | -$36.5K | 0.01% | 276 |
|
|
2024
Q4 | $306K | Sell |
4,046
-1,025
| -20% | -$80.5K | 0.01% | 236 |
|
|
2024
Q3 | $448K | Sell |
5,071
-59
| -1% | -$4.63K | 0.02% | 195 |
|
|
2024
Q2 | $387K | Sell |
5,130
-746
| -13% | -$69.3K | 0.02% | 203 |
|
|
2024
Q1 | $552K | Sell |
5,876
-1,048
| -15% | -$107K | 0.02% | 187 |
|
|
2023
Q4 | $752K | Buy |
6,924
+67
| +1% | +$7.2K | 0.03% | 164 |
|
|
2023
Q3 | $656K | Buy |
6,857
+177
| +3% | +$18.2K | 0.03% | 162 |
|
|
2023
Q2 | $737K | Buy |
6,680
+1,014
| +18% | +$119K | 0.04% | 154 |
|
|
2023
Q1 | $695K | Sell |
5,666
-167
| -3% | -$20.5K | 0.04% | 153 |
|
|
2022
Q4 | $683K | Buy |
5,833
+150
| +3% | +$15.1K | 0.03% | 153 |
|
|
2022
Q3 | $472K | Buy |
5,683
+70
| +1% | +$7.54K | 0.02% | 172 |
|
|
2022
Q2 | $573K | Buy |
5,613
+10
| +0.2% | +$1.18K | 0.03% | 158 |
|
|
2022
Q1 | $755K | Sell |
5,603
-263
| -4% | -$37K | 0.04% | 148 |
|
|
2021
Q4 | $979K | Buy |
5,866
+728
| +14% | +$120K | 0.05% | 138 |
|
|
2021
Q3 | $746K | Sell |
5,138
-365
| -7% | -$59.5K | 0.04% | 136 |
|
|
2021
Q2 | $853K | Buy |
5,503
+464
| +9% | +$62.4K | 0.05% | 123 |
|
|
2021
Q1 | $674K | Sell |
5,039
-174
| -3% | -$24.2K | 0.04% | 129 |
|
|
2020
Q4 | $737K | Buy |
5,213
+89
| +2% | +$11.8K | 0.05% | 126 |
|
|
2020
Q3 | $646K | Sell |
5,124
-2
| -0% | -$215 | 0.05% | 135 |
|
|
2020
Q2 | $501K | Sell |
5,126
-1,312
| -20% | -$121K | 0.05% | 129 |
|
|
2020
Q1 | $531K | Sell |
6,438
-770
| -11% | -$71.6K | 0.05% | 121 |
|
|
2019
Q4 | $735K | Sell |
7,208
-127
| -2% | -$12K | 0.07% | 111 |
|
|
2019
Q3 | $689K | Sell |
7,335
-1,157
| -14% | -$99.2K | 0.06% | 124 |
|
|
2019
Q2 | $716K | Sell |
8,492
-946
| -10% | -$79.6K | 0.06% | 130 |
|
|
2019
Q1 | $800K | Sell |
9,438
-1,358
| -13% | -$112K | 0.07% | 128 |
|
|
2018
Q4 | $802K | Sell |
10,796
-290
| -3% | -$21.7K | 0.06% | 118 |
|
|
2018
Q3 | $947K | Sell |
11,086
-459
| -4% | -$36.9K | 0.08% | 111 |
|
|
2018
Q2 | $920K | Sell |
11,545
-978
| -8% | -$68.9K | 0.08% | 107 |
|
|
2018
Q1 | $832K | Buy |
+12,523
| New | +$826K | 0.07% | 119 |
|
|
2017
Q4 | – | Sell |
-16,752
| Closed | -$869K | – | 141 |
|
|
2017
Q3 | $869K | Sell |
16,752
-1,673
| -9% | -$93.9K | 0.07% | 116 |
|
|
2017
Q2 | $1.09M | Sell |
18,425
-2,497
| -12% | -$135K | 0.09% | 106 |
|
|
2017
Q1 | $1.17M | Buy |
20,922
+295
| +1% | +$16.3K | 0.1% | 107 |
|
|
2016
Q4 | $1.05M | Buy |
+20,627
| New | +$1.06M | 0.09% | 107 |
|
Other funds holding NKE
Aspiriant LLC's NKE Position: Q2 2025 in Review
Aspiriant LLC sold out of Nike (NKE) in Q2 2025, closing a stake of 3,550 shares — an estimated $225K sold.
Aspiriant LLC first reported a position in NKE in Q4 2016 and held it in 33 quarters. The position peaked at $1.17M in Q1 2017. 2,064 funds tracked by Wall St. Rank hold NKE as of Q2 2025.
- Aspiriant LLC reported no remaining Nike position as of Q2 2025 after selling out during the quarter.
- Aspiriant LLC sold 3,550 Nike shares in Q2 2025, an estimated $225K.
- Aspiriant LLC first reported a position in Nike in Q4 2016 and held it in 33 quarters.
- Aspiriant LLC's Nike position peaked at $1.17M in Q1 2017.
- 2,064 funds tracked by Wall St. Rank held Nike as of Q2 2025.
Based on Aspiriant LLC's 13F filing for Q2 2025, filed 29 Jul 2025.